Meta-level question: how do you evaluate evidence for ligandrol when the human data is thin and most trials are small?
I have started logging dose, time, and sleep because otherwise the anecdote is just a mood.
The measured outcome and the hoped-for outcome are rarely the same thing in these threads.
Most of the popular protocols are borrowed from clinical populations and applied to healthy people without comment.
Suppression is real and milder than the AAS equivalent, which is not the same as absent.
Curious whether the popular dose has any basis or is just the convenient one.
Log dose, time and sleep. Ten seconds a day and it turns the anecdote into something you can look at. Side effects was my main issue with ligandrol too.
Read methods.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
